Company Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services.
Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business.
The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016.
DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
| Country | United States |
| Founded | 1994 |
| IPO Date | Oct 31, 1995 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 70,000 |
| CEO | Javier J. Rodriguez |
Contact Details
Address: 2000 16th Street Denver, Colorado 80202 United States | |
| Phone | 310-536-2668 |
| Website | davita.com |
Stock Details
| Ticker Symbol | DVA |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000927066 |
| CUSIP Number | 23918K108 |
| ISIN Number | US23918K1088 |
| Employer ID | 51-0354549 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Javier J. Rodriguez | Chief Executive Officer and Executive Director |
| Joel Ackerman | Chief Financial Officer and Treasurer |
| Kathleen Alyce Waters | Chief Legal and Public Affairs Officer |
| James O. Hearty | Chief Compliance Officer |
| Michael David Staffieri | Chief Operating Officer of Kidney Care |
| Christopher Michael Berry | Group Vice President and Chief Accounting Officer |
| Jim Gustafson | Vice President of Investor Relations |
| Kenneth Gardner Smith | Chief People Officer |
| Misha Palecek | Chief Transformation Officer of U.S. Kidney Care Business |
| Dr. Jeffrey Allen Giullian | Chief Medical Officer of Kidney Care |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 14, 2024 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Jun 10, 2024 | 8-K | Current Report |
| May 13, 2024 | 8-K | Current Report |
| May 10, 2024 | 144 | Filing |
| May 2, 2024 | 10-Q | Quarterly Report |
| May 2, 2024 | 8-K | Current Report |
| May 1, 2024 | 8-K | Current Report |
| Apr 26, 2024 | ARS | Filing |
| Apr 26, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 26, 2024 | DEF 14A | Other definitive proxy statements |